Petmed Express (PETS) closed at $1.07 on November 11, 2026, down 12.0% from the previous close, on volume of 403,288 shares (30-day average 97,938).
Data as of November 11, 2026.
PetMed Express GAAP EPS of -$0.31 misses by $0.20, revenue of $35.8M
Seeking Alpha News (Tue, 10-Nov 4:28 PM ET)
PetMeds Announces Second Quarter Financial Results
Globe Newswire (Tue, 10-Nov 4:05 PM ET)
Here are the major earnings after the close Tuesday
Seeking Alpha News (Tue, 10-Nov 10:00 AM ET)
PetMed Express Q2 Earnings Preview
Seeking Alpha News (Mon, 9-Nov 5:35 PM ET)
Globe Newswire (Mon, 9-Nov 4:05 PM ET)
Globe Newswire (Tue, 27-Oct 4:15 PM ET)
PetMeds Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire (Fri, 2-Oct 4:05 PM ET)
PetMeds Enhances Board of Directors with Appointment of Tamar Elkeles as New Independent Director
Globe Newswire (Mon, 21-Sep 8:30 AM ET)
PetMeds Appoints Jeff Willard as CEO & President and Announces Board Leadership Transition
Globe Newswire (Thu, 17-Sep 8:30 AM ET)
PetMeds Appoints Andrew Parry as Chief Technology Officer
Globe Newswire (Mon, 14-Sep 4:05 PM ET)
PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.
Petmed Express trades on the NASDAQ stock market under the symbol PETS.
As of November 12, 2026, PETS stock price declined to $0.94 with 197,839 million shares trading.
PETS has a beta of 1.24, meaning it tends to be more sensitive to market movements. PETS has a correlation of 0.03 to the broad based SPY ETF.
PETS has a market cap of $20.38 million. This is considered a Sub-Micro Cap stock.
Last quarter Petmed Express reported $36 million in Revenue and -$.31 earnings per share. This beat revenue expectation by $29 million and missed earnings estimates by -$.20.
In the last 3 years, PETS traded as high as $8.27 and as low as $.93.
The top ETF exchange traded funds that PETS belongs to (by Net Assets): VTI, VXF, BSVO, IWC, BUSM.
PETS has underperformed the market in the last year with a price return of -65.1% while the SPY ETF gained +12.5%. PETS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -52.5% and -21.0%, respectively, while the SPY returned -1.0% and -1.4%, respectively.
PETS support price is $1.03 and resistance is $1.10 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PETS shares will trade within this expected range on the day.